Dopamine D2/D3 Receptors in Compulsive Disorders
Dopamine D2/D3 Receptors in Compulsive Disorders
批准号:
7728111
负责人:
james H Woods
金额:
$39.98万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2013-06-30
关键词:
AgonistAnimal ModelBehaviorBehavior TherapyBehavioralBehavioral ModelCocaineDataDiseaseDopamineDopamine AgonistsDopamine ReceptorEatingElementsEvaluationExerciseGamblingGoalsHome environmentIndividualInterventionModelingNatureObsessive compulsive behaviorOperant ConditioningOrganismPharmaceutical PreparationsPharmacological TreatmentPositioning AttributePrevention approachProceduresProcessPsychopathologyQuinpiroleRNA InterferenceRattusResearchRespondentRodentRoleSex BehaviorStimulusTestingThinkingTimeWaterbehavioral pharmacologychemical synthesisconditioningdesignexcessive behaviorneurochemistryprogramspublic health relevancereceptorreinforced behaviorreinforcersextherapy development
中文摘要
描述(由申请人提供):强迫性行为,包括暴饮暴食、赌博、购物、锻炼或吸毒,在没有其他精神疾病的个人中会随着时间的推移而发展。虽然强迫症行为的特点是对某一特定行为的过度投入,但强迫症行为的动物模型表明,另一个定义特征是行为与增强剂的传递脱节。因此,人们可能会强迫赌博,即使他们不经常赢,或者过度购物,即使他们可能不会使用他们购买的东西。我们的假设是,当操作型(工具型,目标跟踪)和应答型(巴甫洛夫式,经典,符号跟踪)的条件反射过程在相同的行为上收敛时,这些类型的增强子脱节行为就会产生。此外,个体必须对多巴胺敏感,当D3/D2激动剂作用于敏化的多巴胺受体时,强迫行为更有可能发生。我们将在三个行为模型中验证这一假设:1)奎比罗诱导对与可卡因相关的刺激的反应;2)奎比罗在水中诱导对水的反应;3)奎比罗作为可卡因或水强化行为的场合创建者。这些模型的行为药理学将用不同的多巴胺激动剂和拮抗剂进行测试,并将研究敏化、目标跟踪和信号跟踪的作用。了解强迫症的环境、行为、神经化学和药理学方面将有望有助于这些衰弱障碍的治疗方法的发展。公共卫生相关性:这项提案的目的是确定各种环境和神经化学因素导致强迫行为(例如,过度赌博、购物、饮食、性行为和吸毒)。我们的假设是,当在敏化的多巴胺受体和刺激的多巴胺受体存在的情况下,建立相同的经典条件反射和操作条件反射行为时,强迫症就会产生。在这项研究工作中,我们将在三个大鼠模型中进行测试。评估选择性多巴胺受体以及沉默D3受体的RNA来改变强迫行为的能力,应该有助于指出这些疾病的可能的药物治疗,而对环境条件的了解将建议行为治疗和预防方法。
英文摘要
DESCRIPTION (provided by applicant): Compulsive behaviors, including excessive eating, gambling, shopping, exercising, or drug-taking, can develop over time in individuals without other psychopathology. Although compulsive behavior is marked by excessive engagement in a particular behavior, animal models of compulsive behavior suggest that another defining feature is behavior that is disconnected from reinforcer delivery. Thus, people may gamble compulsively even though they do not win often, or shop excessively even when they may not use what they have purchased. Our hypothesis is that these types of reinforcer- disconnected behaviors result when both operant (instrumental, goal-tracking) and respondent (Pavlovian, classical, sign-tracking) conditioning processes converge on the same behavior. In addition, individuals must be sensitized to dopamine, and the compulsive behavior is more likely to occur in the presence of a D3/D2 agonist acting on the sensitized dopamine receptors. We will test this hypothesis in three behavioral models: 1) quinpirole-induced responding for stimuli associated with cocaine; 2) quinpirole-induced responding for water in the presence of water; and 3) quinpirole as an occasion setter for either cocaine or water-reinforced behavior. The behavioral pharmacology of these models will be tested with various dopamine agonists and antagonists, and the roles of sensitization, goal-tracking, and sign-tracking will be studied. Understanding the environmental, behavioral, neurochemical, and pharmacological aspects of compulsive disorders will hopefully contribute to the development of treatments for these debilitating disorders. PUBLIC HEALTH RELEVANCE: The purpose of this proposal is to determine various environmental and neurochemical contributors to compulsive behavior (e.g., excessive gambling, shopping, eating, sexual behavior, and drug-taking). Our hypothesis, that compulsions result when the same classically conditioned and operantly conditioned behavior is established in the presence of sensitized dopamine receptors and stimulation of dopamine receptors, will be tested in three rat models in this research effort. Evaluation of the ability of selective dopamine receptors, as well as silencing the RNA for the D3 receptor, to modify the compulsive behavior should help point towards possible pharmacological treatment of these disorders, and understanding of the setting conditions will suggest behavioral therapy and prevention approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical Identification of Better Antimuscarinic Antidepressants
-
批准号:9521089
-
项目类别:
-
资助金额:$59.08万
-
财政年份:2017
-
负责人:james H Woods
-
依托单位:
Preclinical Identification of Better Antimuscarinic Antidepressants
-
批准号:9106052
-
项目类别:
-
资助金额:$61.71万
-
财政年份:2016
-
负责人:james H Woods
-
依托单位:
Dopamine D2/D3 Receptors in Compulsive Disorders
-
批准号:8107619
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2009
-
负责人:james H Woods
-
依托单位:
Dopamine D2/D3 Receptors in Compulsive Disorders
-
批准号:8289580
-
项目类别:
-
资助金额:$46.11万
-
财政年份:2009
-
负责人:james H Woods
-
依托单位:
Dopamine D2/D3 Receptors in Compulsive Disorders
-
批准号:7935212
-
项目类别:
-
资助金额:$46.62万
-
财政年份:2009
-
负责人:james H Woods
-
依托单位:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
-
批准号:7079791
-
项目类别:
-
资助金额:$70.48万
-
财政年份:2006
-
负责人:james H Woods
-
依托单位:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
-
批准号:7228552
-
项目类别:
-
资助金额:$67.83万
-
财政年份:2006
-
负责人:james H Woods
-
依托单位:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
-
批准号:7407488
-
项目类别:
-
资助金额:$68.46万
-
财政年份:2006
-
负责人:james H Woods
-
依托单位:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
-
批准号:7615518
-
项目类别:
-
资助金额:$70.52万
-
财政年份:2006
-
负责人:james H Woods
-
依托单位:
Stress, Rearing, and Ethanol Reinforcement in Monkeys
-
批准号:6807568
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:james H Woods
-
依托单位:
Stress, Rearing, and Ethanol Reinforcement in Monkeys
-
批准号:6943142
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:james H Woods
-
依托单位:
Stress, Rearing, and Ethanol Reinforcement in Monkeys
-
批准号:6598409
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:james H Woods
-
依托单位:
CRH Antagonists for Treatment of Drug Abuse
-
批准号:6782495
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2002
-
负责人:james H Woods
-
依托单位:
CRH Antagonists for Treatment of Drug Abuse
-
批准号:6572610
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2002
-
负责人:james H Woods
-
依托单位:
CRH Antagonists for Treatment of Drug Abuse
-
批准号:6666660
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2002
-
负责人:james H Woods
-
依托单位:
CRH Antagonists for Treatment of Drug Abuse
-
批准号:6947798
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2002
-
负责人:james H Woods
-
依托单位:
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE
-
批准号:6256395
-
项目类别:
-
资助金额:$40.12万
-
财政年份:2001
-
负责人:james H Woods
-
依托单位:
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE
-
批准号:6476003
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2001
-
负责人:james H Woods
-
依托单位:
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE
-
批准号:6624765
-
项目类别:
-
资助金额:$41.04万
-
财政年份:2001
-
负责人:james H Woods
-
依托单位:
BCHE as a Cocaine Antagonist
-
批准号:6317655
-
项目类别:
-
资助金额:$49.59万
-
财政年份:2001
-
负责人:james H Woods
-
依托单位:
海外基金